What is the relative risk or percentage incidence of dementia in individuals with schizophrenia, bipolar disorder, anxiety disorder, depression, and stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dementia Risk Associated with Psychiatric Disorders and Stroke

Direct Answer

Stroke carries the highest absolute risk of dementia (up to 60% develop cognitive impairment, with 18.4% progressing to dementia within 1 year), followed by schizophrenia and bipolar disorder (both approximately 2-fold increased risk), then depression (1.6-2.4-fold increased risk), with anxiety showing the weakest association (1.2-1.3-fold increased risk). 1, 2, 3


Quantified Risk by Condition

1. Stroke: Highest Absolute Risk

  • Up to 60% of stroke survivors develop poststroke cognitive impairment (PSCI) within the first year, with the highest rates occurring shortly after stroke 1
  • 38% develop cognitive impairment without dementia in the first year poststroke 1
  • 18.4% develop dementia within 1 year among those without pre-stroke dementia 1
  • The 10-year cumulative risk of dementia after any stroke is 19.3% compared to 11.0% in those without stroke 4
  • In the Nor-COAST study, 59% had PSCI at 3 months and 51% at 18 months after mostly mild strokes 1

Key modifiers of stroke-related dementia risk:

  • Stroke recurrence dramatically increases dementia risk—the incidence of new dementia is much higher after a second stroke 1
  • Strategic location matters: thalamic infarcts affecting the left frontotemporal region, left thalamus, and right parietal lobe carry particularly high risk 4
  • Presence of white matter hyperintensities at baseline doubles the risk of cognitive impairment in post-stroke populations 1

2. Schizophrenia: 2-4.5-Fold Increased Risk

  • Hazard ratio of 2.87 for subsequent dementia in the Welsh population study 2
  • Hazard ratio of 4.46 in UK Biobank 2
  • Hazard ratio of 2.06 in Taiwanese cohort after adjusting for physical comorbidities 3
  • Hazard ratio of 4.50 specifically for Alzheimer's disease in middle-aged patients 5
  • Hazard ratio of 4.55 for vascular dementia 5

Critical context: Cognitive decline in schizophrenia begins 14 years prior to onset of psychosis with accelerated decline in middle age 6

3. Bipolar Disorder: 2-10-Fold Increased Risk

  • Hazard ratio of 2.80 in the Welsh population study 2
  • Hazard ratio of 3.65 in UK Biobank 2
  • Hazard ratio of 2.14 in Taiwanese cohort—the highest among all severe mental illnesses 3
  • Hazard ratio of 10.37 specifically for Alzheimer's disease in middle-aged patients 5
  • Hazard ratio of 4.45 for vascular dementia 5

Bipolar disorder confers the greatest risk of developing dementia among all severe mental illnesses when comparing head-to-head 3

4. Depression: 1.6-2.7-Fold Increased Risk

  • Hazard ratio of 1.63 in the Welsh population study 2
  • Hazard ratio of 2.39 in UK Biobank 2
  • Hazard ratio of 1.60 in Taiwanese cohort 3
  • Pooled relative risk of 1.96 for all-cause dementia in meta-analysis 7
  • Pooled relative risk of 1.90 for Alzheimer's disease 7
  • Pooled relative risk of 2.71 for vascular dementia 7
  • Hazard ratio of 8.92 specifically for Alzheimer's disease in middle-aged patients 5

Important nuances:

  • Associations are stronger with shorter follow-up periods, suggesting depression may represent prodromal dementia in some cases 7
  • Severe and late-onset depression carry higher dementia risk than mild or early-onset depression 7
  • Late onset of depressive symptoms should alert clinicians to possible incipient dementia 2

5. Anxiety Disorder: Weakest Association (1.2-1.3-Fold)

  • Hazard ratio of 1.34 in UK Biobank 2
  • Pooled relative risk of 1.18 (95% CI: 0.96-1.45) in meta-analysis, with no evidence of overall association 7
  • Findings regarding anxiety are mixed and inconsistent across studies 7

The evidence for anxiety as an independent dementia risk factor is the weakest among all conditions examined 7


Comparative Risk Hierarchy

When comparing all conditions directly:

  1. Stroke has the highest absolute risk (up to 60% develop cognitive impairment) 1
  2. Bipolar disorder has the highest relative risk among psychiatric disorders (HR: 2.14-10.37 depending on dementia subtype) 3, 5
  3. Schizophrenia follows closely (HR: 2.06-4.55) 2, 3, 5
  4. Depression shows moderate increased risk (HR: 1.60-2.71) 2, 3, 7
  5. Anxiety shows minimal to no increased risk (HR: 1.18-1.34) 2, 7

Clinical Implications and Risk Modification

For Stroke Patients:

  • Aggressive secondary stroke prevention is critical as recurrence dramatically increases dementia risk 4
  • Target blood pressure <140/90 mmHg (or <120 mmHg in appropriate patients) 4
  • Optimize diabetes management, lipid control, and antiplatelet therapy 4
  • Age is a key vulnerability factor with greater cognitive decline acceleration in older stroke survivors 4

For Psychiatric Disorder Patients:

  • All severe mental illnesses increase dementia risk, warranting close cognitive monitoring in middle-aged and elderly patients 3, 5
  • There is a steep increase in psychiatric disorder incidence in the years prior to dementia diagnosis, reaching a peak in the year before dementia diagnosis 2
  • Anxiolytic use does not appear to increase dementia risk in patients with severe mental illness 3

Common Pitfall:

Do not dismiss late-onset psychiatric symptoms as "just depression" or "just anxiety"—these may represent prodromal dementia, particularly when onset occurs after age 60 2, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Which Severe Mental Illnesses Most Increase the Risk of Developing Dementia? Comparing the Risk of Dementia in Patients with Schizophrenia, Major Depressive Disorder and Bipolar Disorder.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2023

Guideline

Thalamic Infarct and Cognitive Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.